omega-n-methylarginine has been researched along with lu 135252 in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (lu 135252) | Trials (lu 135252) | Recent Studies (post-2010) (lu 135252) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 196 | 13 | 14 |
| Protein | Taxonomy | omega-n-methylarginine (IC50) | lu 135252 (IC50) |
|---|---|---|---|
| Endothelin receptor type B | Homo sapiens (human) | 0.016 | |
| Endothelin-1 receptor | Homo sapiens (human) | 0.0008 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gonon, AT; Gourine, AV; Pernow, J | 1 |
1 other study(ies) available for omega-n-methylarginine and lu 135252
| Article | Year |
|---|---|
Cardioprotection from ischemia and reperfusion injury by an endothelin A-receptor antagonist in relation to nitric oxide production.
Topics: Animals; Endothelin Receptor Antagonists; Endothelins; Female; Hemodynamics; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide; omega-N-Methylarginine; Phenylpropionates; Pyrimidines; Receptor, Endothelin A; Swine | 2000 |